Learning Center

Ahmad Sediq, PhD, is a pharmacist with a PhD degree in pharmaceutical technology from Leiden University in the Netherlands. Dr Sediq worked as a formulation scientist at Janssen Vaccines in the Netherlands, where he was responsible for late-stage development and commercial launch of adeno-associated virus- (AAV)-vector-based vaccine products for Ebola and human immunodeficiency virus (HIV). He joined Lonza DPS in 2018, where he was principal scientist and group leader in the Formulation Development group. At Lonza, his team was responsible for early- and late-stage drug product development of various biological formats. In 2022, Dr Sediq joined Roche/Genentech, where he is taking the lead of early- and late-stage drug product design and development for treatment of inflammatory bowel disease and lung cancer. 

Dr Sediq is interested in applying his technical and scientific knowledge into pharmaceutical care and treatment. Therefore, he is passionate of performing research at the interface of pharmaceutical technology and clinical practice.